RHA® Collection
HintMD
Daxibotulinumtoxin A
Visit Site
Our Mission
Revance is a biotechnology company focused on innovative aesthetic and therapeutic offerings, as well as financial technology services for aesthetic practices.
Facts, Figures & Trends
Aesthetics
Neuromodulators are the most performed minimally invasive cosmetic procedures, followed by dermal fillers 1
View Products
Therapeutics
There are 12 Approved Therapeutic Indications for Botulinum Toxin Type A in the U.S. and hundreds of potential indications 2
ExploreIn the News
Stock Quote
$26.29
EXCHANGE
NYSE (US DOLLAR)
0.58
VOLUME
514,134
Price could be delayed by up to 15 mins
Set a New Standard With Us
Revance is building the prestige market for aesthetics with expertly created products, available in select practices who produce exceptional outcomes.
Visit SiteReferences
- The American Society of Plastic Surgeons. 2019 Plastic Surgery Statistic Report. Available at: https://www.plasticsurgery.org/documents/News/Statistics/2019/plastic-surgery-statistics-full-report-2019.pdf. Accessed July 2020
- Time Magazine, January 16, 2017, How BOTOX Became the Drug That’s Treating Everything. Available at: https://time.com/4623409/botox-drug-treating-everything/. Accessed April 2020